Evidence map›Paper›PMID 39258531›Full record

Trial reportJournal of the American Heart Association2024

Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study.

Shoujiang You, Yanan Wang, Xia Wang, Toshiki Maeda, Menglu Ouyang, Qiao Han, Qiang Li, Lili Song, Yang Zhao, Chen Chen and 13 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01422616 (An International Randomised Controlled Trial to Establish the Effects of Low-dose rtPA and the Effects of Early Intensive Blood Pressure Lowering in Patients With Acute Ischaemic Stroke), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01422616 phase3completednot on this map

An International Randomised Controlled Trial to Establish the Effects of Low-dose rtPA and the Effects of Early Intensive Blood Pressure Lowering in Patients With Acute Ischaemic Stroke

TypeinterventionalSponsorThe George InstituteRan2012 to 2018Enrolled4,587ConditionsIschemic Stroke, High Blood PressureArmsLow-dose rtPA, Standard-dose rtPA, Intensive blood pressure (BP) lowering, BP management policies
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Validation and simplification of the MR PREDICTS @24H model for outcome prediction after endovascular thrombectomy for acute ischemic stroke.International journal of stroke : official journal of the International Stroke Society · 2026
    Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Predictive Value of RMedicina (Kaunas, Lithuania) · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Shoujiang YouDepartment of Neurology and Clinical Research Center of Neurological Disease The Second Affiliated Hospital of SooChow University Suzhou China.ORCID 0000-0002-6059-0853
Yanan WangDepartment of Neurology, West China Hospital Sichuan University Chengdu Sichuan China.ORCID 0000-0002-3089-9462
Xia WangThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0002-1684-7076
Toshiki MaedaThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0002-5634-9792
Menglu OuyangThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0001-7917-6858
Qiao HanDepartment of Neurology Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine Suzhou China.
Qiang LiThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.
Lili SongThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0002-6105-1720
Yang ZhaoThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.
Chen ChenThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0002-8960-8797
Candice DelcourtThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0003-2257-4286
Xinwen RenThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0002-5235-894X
Cheryl CarcelThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0001-8942-953X
Zien ZhouThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0001-6543-7113
Yongjun CaoDepartment of Neurology and Clinical Research Center of Neurological Disease The Second Affiliated Hospital of SooChow University Suzhou China.ORCID 0000-0002-8135-8914
Chun-Feng LiuDepartment of Neurology and Clinical Research Center of Neurological Disease The Second Affiliated Hospital of SooChow University Suzhou China.ORCID 0000-0002-8364-0219
Danni ZhengThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.
Hisatomi ArimaDepartment of Preventive Medicine and Public Health Fukuoka University Fukuoka Japan.ORCID 0000-0002-2064-2014
Thompson G RobinsonDepartment of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre University of Leicester Leicester UK.ORCID 0000-0003-2144-2468
Xiaoying ChenThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0002-8367-542X
Richard I LindleyThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0002-0104-5679
John ChalmersThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0002-9931-0580
Craig S AndersonThe George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia.ORCID 0000-0002-7248-4863

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study was conducted to determine optimal predictive ability of National Institutes of Health Stroke Scale (NIHSS) measurements at baseline, 24 hours, and change from baseline to 24 hours after thrombolysis on functional recovery in patients with acute ischemic stroke who participated in the ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study). METHODS AND

resultsENCHANTED was an international, multicenter, 2×2 quasifactorial, prospective, randomized open trial of low-dose versus standard-dose intravenous alteplase and intensive versus guideline-recommended blood pressure lowering in thrombolysis-eligible patients with acute ischemic stroke. Absolute (baseline minus 24 hours) and percentage (absolute change/baseline × 100) changes in NIHSS scores were calculated. Receiver operating characteristic curve analyses assessed performance of different NIHSS measurements on 90-day favorable functional recovery (modified Rankin Scale [mRS] score 0-2) and excellent functional recovery (mRS score 0-1). Youden index was used to identify optimal predictor cutoff points. A total of 4410 patients in the ENCHANTED trial were enrolled. The 24-hour NIHSS score had the highest discriminative ability for predicting favorable 90-day functional recovery (mRS score 0-2; area under the curve 0.866 versus 0.755, 0.689, 0.764;

conclusionsIn thrombolysis-eligible patients with acute ischemic stroke, 24-hour NIHSS score (optimal cutpoint of 4) is the strongest predictor of 90-day functional recovery over baseline and early change of NIHSS score. REGISTRATION: URL: https://clinicaltrials.gov. Unique Identifier: NCT01422616.

Indexed as

Fibrinolytic AgentsIschemic StrokeRecovery of FunctionThrombolytic TherapyTissue Plasminogen ActivatorAgedAged, 80 and overDisability EvaluationFemaleFunctional StatusHumansMaleMiddle AgedPredictive Value of TestsPrognosisProspective StudiesFibrinolytic AgentsTissue Plasminogen ActivatorENCHANTEDischemic strokeNIHSS scorepredictorthrombolysis

Identifiers

PMID39258531
PMCPMC11935628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.